RNU5A-4P: A Drug Target / Disease Biomarker (G100873870)

Target Name: RNU5A-4P

NCBI ID: G100873870

RNU5A-4P

Other Name(s): RNA, U5A small nuclear 4, pseudogene

RNU5A-4P: A Drug Target / Disease Biomarker

RNAU5A-4P, also known as U5A-4P, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its role in the development and progression of these diseases.

RNAU5A-4P is a small RNA molecule that consists of 54 amino acid residues. It is primarily expressed in the brain and is involved in various cellular processes, including cell adhesion, migration, and survival. RNAU5A-4P has been shown to play a critical role in the regulation of brain development and function, and is often used as a protein or RNA target for drugs that are designed to modulate these processes.

One of the key functions of RNAU5A-4P is its role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and is critical for the development and maintenance of tissues and organs during development. RNAU5A-4P has been shown to be involved in the regulation of cell adhesion, and has been shown to play a role in the development of various diseases, including cancer.

RNAU5A-4P has also been shown to be involved in the regulation of cell migration. Migration is the process by which cells move from one location to another in order to respond to changes in the environment, and is critical for the development and maintenance of tissues and organs during development. RNAU5A-4P has been shown to be involved in the regulation of cell migration, and has been shown to play a role in the development of various diseases, including cancer.

RNAU5A-4P has also been shown to be involved in the regulation of cellular stress responses. Stress responses are critical for the survival of cells, and RNAU5A-4P has been shown to play a role in the regulation of cellular stress responses, including the stress response caused by exposure to chemotherapy drugs.

In addition to its role in cell adhesion, migration, and stress responses, RNAU5A-4P has also been shown to be involved in the regulation of cellular processes that are critical for the development and maintenance of tissues and organs. For example, RNAU5A-4P has been shown to play a role in the regulation of cell proliferation, and has been shown to be involved in the development of various diseases, including cancer.

RNAU5A-4P is also a potential biomarker for various diseases, including cancer. The expression of RNAU5A-4P has been shown to be altered in a variety of diseases, including cancer, and studies have shown that RNAU5A-4P may be a useful biomarker for the diagnosis and treatment of these diseases.

In conclusion, RNAU5A-4P is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its role in the development and progression of these diseases. Further research is needed to fully understand the role of RNAU5A-4P in the regulation of cellular processes and its potential as a drug target or biomarker.

Protein Name: RNA, U5A Small Nuclear 4, Pseudogene

The "RNU5A-4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU5A-4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets